Clinical Trial Update: Use of TDF in Patients With Inactive Chronic Hepatitis B Infection [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating tenofovir disoproxil fumarate (TDF) in patients with inactive chronic hepatitis B; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Hepatitis B, Chronic | Phase 3 | Status: COMPLETED